Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder Cancer-Reference-Cited by-同舟云学术

Expression and Significance of Vascular Endothelial Growth Factor Receptor 2 in Bladder Cancer

Published:2006-04 Issue:4 Volume:175 Page:1245-1252
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Xia Guangbin¹,Kumar S. Ram²³,Hawes Debra²,Cai Jie⁴,Hassanieh Loubna⁵,Groshen Susan⁶,Zhu Sutao¹,Masood Rizwan²,Quinn David I.¹,Broek Daniel⁷,Stein John P.⁴,Gill Parkash S.¹²

Affiliation:

1. Department of Medicine, Keck School of Medicine of the University of Southern California, California

2. Department of Pathology, Keck School of Medicine of the University of Southern California, California

3. Department of Surgery, Keck School of Medicine of the University of Southern California, California

4. Department of Urology, Keck School of Medicine of the University of Southern California, California

5. Vasgene Therapeutics, Inc., Los Angeles, California

6. Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, California

7. Department of Biochemistry and Molecular Biology, Keck School of Medicine of the University of Southern California, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

2. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C;Ristimaki;J Biol Chem,1998

3. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF;Sodhi;Biochem Biophys Res Commun,2001

4. Mutant p53 in bone marrow stromal cells increases VEGF expression and supports leukemia cell growth;Narendran;Exp Hematol,2003

5. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy;Slaton;J Urol,2004

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors;Journal of Molecular Structure;2024-06

2. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior;Investigative Opthalmology & Visual Science;2024-02-21

3. VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder;BMC Urology;2022-12-29

4. Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer;Pharmaceutics;2022-10-18

5. Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation;Molecules;2022-08-08